← Open Payments lookup

NPI 1922005370: Open Payments

NPI 1922005370. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,580 in 77 payments from 13 companies in 2025. Trend: 2023 $2,229 · 2024 $2,444 · 2025 $1,580

Food & beverage: $1,580
CompanyPaymentsAmount
Novo Nordisk Inc32$638
Amgen Inc.11$317
ABBVIE INC.12$167
AstraZeneca Pharmaceuticals LP9$139
Radius Health, Inc.2$117
GlaxoSmithKline, LLC.2$37
Lilly USA, LLC2$35
Boehringer Ingelheim Pharmaceuticals, Inc.2$33
Exact Sciences Corporation1$26
Bayer Healthcare Pharmaceuticals Inc.1$20

Products named: Ozempic, EVENITY, Wegovy, VRAYLAR, Repatha, Tymlos, Rybelsus, BREZTRI.